Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protamine sulfate in TAVI
NCT02974660Phase 4Completed
- Sponsor
- Medical University of Warsaw
- Start
- Dec 2016
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of protamine in aortic valve stenosis (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Bleeding complications according to VARC criteria at 48 hours. Started Dec 2016; status: completed.
02
Drugs
protamine
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT02974660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02974660.